Zimmer Biomet Holdings, Inc.
NYSEZimmer Biomet Holdings reports Q1 2026 results on May 22 carrying the fresh bruise of a 13% one-day drop from its prior quarterly print — and options traders are already moving for cover. The clearest signal heading into Thursday's release is in the options market. The put/call ratio has jumped to 0.79, more than two standard deviations above its 20-day average of 0.72. That is not…
Snapshot as of 22 Jun 2026
Zimmer Biomet Holdings reports Q1 2026 results on May 22 carrying the fresh bruise of a 13% one-day drop from its prior quarterly print — and options traders are already moving for cover. The clearest signal heading…
ZBH enters its May 6 earnings call having just absorbed a wave of coordinated analyst target cuts — a rare pre-print repricing that sets up one of the more charged setups the orthopedic giant has seen in years. The…
Short interest in Zimmer Biomet has jumped 35% over the past month to 5.2% of the float ahead of Monday's earnings print. Analysts remain divided with 17 hold ratings and no clear consensus target, while options…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ZBH — free to start on ORTEX.
Sign up for free →Open ZBH on ORTEX